{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-24-006349","form_type":"8-K","ticker":"NXL","cik":"0001527352","company_name":"Nexalin Technology, Inc.","filed_at":"2024-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.377576+00:00","generated_at":"2026-05-31T03:36:34.161717+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Nexalin appoints Carolyn Shelton as SVP Quality, Regulatory & Clinical Affairs","bullets":["Carolyn Shelton appointed SVP Quality, Regulatory and Clinical Affairs effective Sept 16, 2024.","Base salary of $300,000; annual discretionary bonus of $40,000 based on milestones.","Stock options valued at $60,000 under 2023 Equity Incentive Plan, vesting equally over 3 years from Sept 16, 2025.","Prior roles include VP Regulatory/Quality at Openwater Health, Advanced Sterilization Products, and Medtronic.","Relocation expenses up to $5,000; five weeks paid time off per year."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-24-006349","json":"https://secwatch.observer/filing/0001829126-24-006349.json","markdown":"https://secwatch.observer/filing/0001829126-24-006349.md","text":"https://secwatch.observer/filing/0001829126-24-006349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624006349/0001829126-24-006349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624006349/nexalintec_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T03:36:34.161717+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5f1d3b78d0","claim":"Carolyn Shelton was appointed as Senior Vice President Quality, Regulatory and Clinical Affairs at Nexalin Technology, Inc..","evidence_excerpt":"On September 16, 2024, Nexalin Technology, Inc. (“Nexalin”) appointed Carolyn Shelton as Senior Vice President Quality, Regulatory and Clinical Affairs, effective as of September 16, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624006349/0001829126-24-006349-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President Quality, Regulatory and Clinical Affairs"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}